Short description
Vectura focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases.
Description
Vectura Group is a product development company that focuses on the development of pharmaceutical therapies for the treatment of airways-related diseases. This growing market includes asthma and chronic obstructive pulmonary disease (COPD) and is estimated to be worth in excess of $30 billion worldwide.
Last funding
Absolutely Noaccess
Sign in for full access
Total funding
$$43214321
Sign in for full access
Location
Chippenham, Wiltshire, United Kingdom, Europe
Founded on
January 1, 1997
Exited on
August 29, 2008
Went public on
August 29, 2008
Stock symbol
VEC
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$56378 - 90123
Sign in for full access
Investors
Nopepepe, Noway Youcantaccess, Uh Ohhhh, Noway Youcantaccess
Sign in for full access
Funding rounds count
1
Portfolio organisations count
Blurry Noaccess, Blurry Noaccess
Sign in for full access
Lead investments count
1
Exits count
No Way, Noaccess
Sign in for full access
IPO exits count
1